Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
This report aims to provide a comprehensive presentation of the global market for Anti-Infective Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Drugs. This report contains market size and forecasts of Anti-Infective Drugs in global, including the following market information:
Global Anti-Infective Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Infective Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Infective Drugs companies in 2022 (%)
The global Anti-Infective Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
OTC Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-Infective Drugs include GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Wyeth, Sanofi-Aventis and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Infective Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Infective Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Infective Drugs Market Segment Percentages, by Type, 2022 (%)
OTC
Rx Drugs
Global Anti-Infective Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Infective Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Drugs Store
Other
Global Anti-Infective Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Infective Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Infective Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Infective Drugs revenues share in global market, 2022 (%)
Key companies Anti-Infective Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Infective Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Wyeth
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
MerLion Pharma
Theravance
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Infective Drugs, market overview.
Chapter 2: Global Anti-Infective Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Infective Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Infective Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Infective Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Infective Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Infective Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Infective Drugs Overall Market Size
2.1 Global Anti-Infective Drugs Market Size: 2022 VS 2029
2.2 Global Anti-Infective Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Infective Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Infective Drugs Players in Global Market
3.2 Top Global Anti-Infective Drugs Companies Ranked by Revenue
3.3 Global Anti-Infective Drugs Revenue by Companies
3.4 Global Anti-Infective Drugs Sales by Companies
3.5 Global Anti-Infective Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Infective Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Infective Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Infective Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Infective Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Infective Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Infective Drugs Market Size Markets, 2022 & 2029
4.1.2 OTC
4.1.3 Rx Drugs
4.2 By Type - Global Anti-Infective Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Infective Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-Infective Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-Infective Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-Infective Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-Infective Drugs Sales, 2018-2023
4.3.2 By Type - Global Anti-Infective Drugs Sales, 2024-2029
4.3.3 By Type - Global Anti-Infective Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Anti-Infective Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Infective Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application - Global Anti-Infective Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Infective Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-Infective Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-Infective Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-Infective Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-Infective Drugs Sales, 2018-2023
5.3.2 By Application - Global Anti-Infective Drugs Sales, 2024-2029
5.3.3 By Application - Global Anti-Infective Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Anti-Infective Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Infective Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-Infective Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Infective Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-Infective Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-Infective Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-Infective Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-Infective Drugs Sales, 2018-2023
6.3.2 By Region - Global Anti-Infective Drugs Sales, 2024-2029
6.3.3 By Region - Global Anti-Infective Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-Infective Drugs Revenue, 2018-2029
6.4.2 By Country - North America Anti-Infective Drugs Sales, 2018-2029
6.4.3 US Anti-Infective Drugs Market Size, 2018-2029
6.4.4 Canada Anti-Infective Drugs Market Size, 2018-2029
6.4.5 Mexico Anti-Infective Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-Infective Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Anti-Infective Drugs Sales, 2018-2029
6.5.3 Germany Anti-Infective Drugs Market Size, 2018-2029
6.5.4 France Anti-Infective Drugs Market Size, 2018-2029
6.5.5 U.K. Anti-Infective Drugs Market Size, 2018-2029
6.5.6 Italy Anti-Infective Drugs Market Size, 2018-2029
6.5.7 Russia Anti-Infective Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Infective Drugs Market Size, 2018-2029
6.5.9 Benelux Anti-Infective Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-Infective Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Anti-Infective Drugs Sales, 2018-2029
6.6.3 China Anti-Infective Drugs Market Size, 2018-2029
6.6.4 Japan Anti-Infective Drugs Market Size, 2018-2029
6.6.5 South Korea Anti-Infective Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Infective Drugs Market Size, 2018-2029
6.6.7 India Anti-Infective Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-Infective Drugs Revenue, 2018-2029
6.7.2 By Country - South America Anti-Infective Drugs Sales, 2018-2029
6.7.3 Brazil Anti-Infective Drugs Market Size, 2018-2029
6.7.4 Argentina Anti-Infective Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Infective Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-Infective Drugs Sales, 2018-2029
6.8.3 Turkey Anti-Infective Drugs Market Size, 2018-2029
6.8.4 Israel Anti-Infective Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Infective Drugs Market Size, 2018-2029
6.8.6 UAE Anti-Infective Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Anti-Infective Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Anti-Infective Drugs Major Product Offerings
7.2.4 Merck Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Anti-Infective Drugs Major Product Offerings
7.3.4 Pfizer Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Anti-Infective Drugs Major Product Offerings
7.4.4 Novartis AG Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Gilead Sciences
7.5.1 Gilead Sciences Company Summary
7.5.2 Gilead Sciences Business Overview
7.5.3 Gilead Sciences Anti-Infective Drugs Major Product Offerings
7.5.4 Gilead Sciences Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Gilead Sciences Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Anti-Infective Drugs Major Product Offerings
7.6.4 Abbott Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 Wyeth
7.7.1 Wyeth Company Summary
7.7.2 Wyeth Business Overview
7.7.3 Wyeth Anti-Infective Drugs Major Product Offerings
7.7.4 Wyeth Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Wyeth Key News & Latest Developments
7.8 Sanofi-Aventis
7.8.1 Sanofi-Aventis Company Summary
7.8.2 Sanofi-Aventis Business Overview
7.8.3 Sanofi-Aventis Anti-Infective Drugs Major Product Offerings
7.8.4 Sanofi-Aventis Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Sanofi-Aventis Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Anti-Infective Drugs Major Product Offerings
7.9.4 Bristol-Myers Squibb Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Johnson
7.10.1 Johnson Company Summary
7.10.2 Johnson Business Overview
7.10.3 Johnson Anti-Infective Drugs Major Product Offerings
7.10.4 Johnson Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Johnson Key News & Latest Developments
7.11 Roche Pharma AG
7.11.1 Roche Pharma AG Company Summary
7.11.2 Roche Pharma AG Anti-Infective Drugs Business Overview
7.11.3 Roche Pharma AG Anti-Infective Drugs Major Product Offerings
7.11.4 Roche Pharma AG Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Roche Pharma AG Key News & Latest Developments
7.12 Nanosphere
7.12.1 Nanosphere Company Summary
7.12.2 Nanosphere Anti-Infective Drugs Business Overview
7.12.3 Nanosphere Anti-Infective Drugs Major Product Offerings
7.12.4 Nanosphere Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Nanosphere Key News & Latest Developments
7.13 NanoViricides
7.13.1 NanoViricides Company Summary
7.13.2 NanoViricides Anti-Infective Drugs Business Overview
7.13.3 NanoViricides Anti-Infective Drugs Major Product Offerings
7.13.4 NanoViricides Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.13.5 NanoViricides Key News & Latest Developments
7.14 Novabay Pharmaceuticals
7.14.1 Novabay Pharmaceuticals Company Summary
7.14.2 Novabay Pharmaceuticals Business Overview
7.14.3 Novabay Pharmaceuticals Anti-Infective Drugs Major Product Offerings
7.14.4 Novabay Pharmaceuticals Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Novabay Pharmaceuticals Key News & Latest Developments
7.15 Obetech
7.15.1 Obetech Company Summary
7.15.2 Obetech Business Overview
7.15.3 Obetech Anti-Infective Drugs Major Product Offerings
7.15.4 Obetech Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Obetech Key News & Latest Developments
7.16 Optimer Pharmaceuticals
7.16.1 Optimer Pharmaceuticals Company Summary
7.16.2 Optimer Pharmaceuticals Business Overview
7.16.3 Optimer Pharmaceuticals Anti-Infective Drugs Major Product Offerings
7.16.4 Optimer Pharmaceuticals Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Optimer Pharmaceuticals Key News & Latest Developments
7.17 Basilea Pharmaceutica AG
7.17.1 Basilea Pharmaceutica AG Company Summary
7.17.2 Basilea Pharmaceutica AG Business Overview
7.17.3 Basilea Pharmaceutica AG Anti-Infective Drugs Major Product Offerings
7.17.4 Basilea Pharmaceutica AG Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Basilea Pharmaceutica AG Key News & Latest Developments
7.18 Daiichi Sankyo
7.18.1 Daiichi Sankyo Company Summary
7.18.2 Daiichi Sankyo Business Overview
7.18.3 Daiichi Sankyo Anti-Infective Drugs Major Product Offerings
7.18.4 Daiichi Sankyo Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Daiichi Sankyo Key News & Latest Developments
7.19 MerLion Pharma
7.19.1 MerLion Pharma Company Summary
7.19.2 MerLion Pharma Business Overview
7.19.3 MerLion Pharma Anti-Infective Drugs Major Product Offerings
7.19.4 MerLion Pharma Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.19.5 MerLion Pharma Key News & Latest Developments
7.20 Theravance
7.20.1 Theravance Company Summary
7.20.2 Theravance Business Overview
7.20.3 Theravance Anti-Infective Drugs Major Product Offerings
7.20.4 Theravance Anti-Infective Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Theravance Key News & Latest Developments
8 Global Anti-Infective Drugs Production Capacity, Analysis
8.1 Global Anti-Infective Drugs Production Capacity, 2018-2029
8.2 Anti-Infective Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Infective Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Infective Drugs Supply Chain Analysis
10.1 Anti-Infective Drugs Industry Value Chain
10.2 Anti-Infective Drugs Upstream Market
10.3 Anti-Infective Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Infective Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Infective Drugs in Global Market
Table 2. Top Anti-Infective Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Infective Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Infective Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Infective Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Infective Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Infective Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anti-Infective Drugs Product Type
Table 9. List of Global Tier 1 Anti-Infective Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Infective Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Infective Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Infective Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Infective Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Infective Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Infective Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Anti-Infective Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Infective Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Infective Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Infective Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Infective Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Anti-Infective Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Infective Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Infective Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Infective Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Infective Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Infective Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Infective Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Infective Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Infective Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Infective Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Infective Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Infective Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Infective Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Infective Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Infective Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Infective Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Infective Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Infective Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Infective Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Infective Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Infective Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Infective Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Infective Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Infective Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Infective Drugs Sales, (K Units), 2024-2029
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Anti-Infective Drugs Product Offerings
Table 48. GlaxoSmithKline Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Anti-Infective Drugs Product Offerings
Table 52. Merck Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Anti-Infective Drugs Product Offerings
Table 56. Pfizer Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Anti-Infective Drugs Product Offerings
Table 60. Novartis AG Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Novartis AG Key News & Latest Developments
Table 62. Gilead Sciences Company Summary
Table 63. Gilead Sciences Anti-Infective Drugs Product Offerings
Table 64. Gilead Sciences Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Gilead Sciences Key News & Latest Developments
Table 66. Abbott Company Summary
Table 67. Abbott Anti-Infective Drugs Product Offerings
Table 68. Abbott Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Abbott Key News & Latest Developments
Table 70. Wyeth Company Summary
Table 71. Wyeth Anti-Infective Drugs Product Offerings
Table 72. Wyeth Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Wyeth Key News & Latest Developments
Table 74. Sanofi-Aventis Company Summary
Table 75. Sanofi-Aventis Anti-Infective Drugs Product Offerings
Table 76. Sanofi-Aventis Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Sanofi-Aventis Key News & Latest Developments
Table 78. Bristol-Myers Squibb Company Summary
Table 79. Bristol-Myers Squibb Anti-Infective Drugs Product Offerings
Table 80. Bristol-Myers Squibb Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Bristol-Myers Squibb Key News & Latest Developments
Table 82. Johnson Company Summary
Table 83. Johnson Anti-Infective Drugs Product Offerings
Table 84. Johnson Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Johnson Key News & Latest Developments
Table 86. Roche Pharma AG Company Summary
Table 87. Roche Pharma AG Anti-Infective Drugs Product Offerings
Table 88. Roche Pharma AG Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Roche Pharma AG Key News & Latest Developments
Table 90. Nanosphere Company Summary
Table 91. Nanosphere Anti-Infective Drugs Product Offerings
Table 92. Nanosphere Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Nanosphere Key News & Latest Developments
Table 94. NanoViricides Company Summary
Table 95. NanoViricides Anti-Infective Drugs Product Offerings
Table 96. NanoViricides Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. NanoViricides Key News & Latest Developments
Table 98. Novabay Pharmaceuticals Company Summary
Table 99. Novabay Pharmaceuticals Anti-Infective Drugs Product Offerings
Table 100. Novabay Pharmaceuticals Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Novabay Pharmaceuticals Key News & Latest Developments
Table 102. Obetech Company Summary
Table 103. Obetech Anti-Infective Drugs Product Offerings
Table 104. Obetech Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Obetech Key News & Latest Developments
Table 106. Optimer Pharmaceuticals Company Summary
Table 107. Optimer Pharmaceuticals Anti-Infective Drugs Product Offerings
Table 108. Optimer Pharmaceuticals Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Optimer Pharmaceuticals Key News & Latest Developments
Table 110. Basilea Pharmaceutica AG Company Summary
Table 111. Basilea Pharmaceutica AG Anti-Infective Drugs Product Offerings
Table 112. Basilea Pharmaceutica AG Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. Basilea Pharmaceutica AG Key News & Latest Developments
Table 114. Daiichi Sankyo Company Summary
Table 115. Daiichi Sankyo Anti-Infective Drugs Product Offerings
Table 116. Daiichi Sankyo Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Daiichi Sankyo Key News & Latest Developments
Table 118. MerLion Pharma Company Summary
Table 119. MerLion Pharma Anti-Infective Drugs Product Offerings
Table 120. MerLion Pharma Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. MerLion Pharma Key News & Latest Developments
Table 122. Theravance Company Summary
Table 123. Theravance Anti-Infective Drugs Product Offerings
Table 124. Theravance Anti-Infective Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. Theravance Key News & Latest Developments
Table 126. Anti-Infective Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Anti-Infective Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Anti-Infective Drugs Production by Region, 2018-2023 (K Units)
Table 129. Global Anti-Infective Drugs Production by Region, 2024-2029 (K Units)
Table 130. Anti-Infective Drugs Market Opportunities & Trends in Global Market
Table 131. Anti-Infective Drugs Market Drivers in Global Market
Table 132. Anti-Infective Drugs Market Restraints in Global Market
Table 133. Anti-Infective Drugs Raw Materials
Table 134. Anti-Infective Drugs Raw Materials Suppliers in Global Market
Table 135. Typical Anti-Infective Drugs Downstream
Table 136. Anti-Infective Drugs Downstream Clients in Global Market
Table 137. Anti-Infective Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Infective Drugs Segment by Type in 2022
Figure 2. Anti-Infective Drugs Segment by Application in 2022
Figure 3. Global Anti-Infective Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Infective Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Infective Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Infective Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Infective Drugs Revenue in 2022
Figure 9. By Type - Global Anti-Infective Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Infective Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Infective Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Infective Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Anti-Infective Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Infective Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Infective Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Infective Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Anti-Infective Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Infective Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Infective Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Infective Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Infective Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Infective Drugs Sales Market Share, 2018-2029
Figure 23. US Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Infective Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Infective Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Infective Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Infective Drugs Sales Market Share, 2018-2029
Figure 37. China Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Infective Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Infective Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Infective Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Infective Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Infective Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Infective Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Infective Drugs by Region, 2022 VS 2029
Figure 54. Anti-Infective Drugs Industry Value Chain
Figure 55. Marketing Channels
